8-K 1 a8-k.txt 8-K ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): AUGUST 10, 2000 ------------------ HORIZON PHARMACIES, INC. (Exact name of Registrant as specified in its charter) Delaware 000-22403 75-2441557 (State or other (Commission File Number) (I.R.S. Employer jurisdiction of incorporation) Identification Number) 531 W. MAIN STREET 75020 SUITE 100 (Zip code) DENISON, TEXAS (Address of principal executive offices) Registrant's telephone number, including area code: (903) 465-2397 NOT APPLICABLE (Former name or former address, if changed since last report) ================================================================================ ITEM 5. OTHER EVENTS On August 10, 2000, HORIZON Pharmacies, Inc. ("Horizon") announced that it had signed an engagement letter with Southwest Securities whereby Southwest Securities agreed to act as exclusive financial advisor to Horizon with respect to exploring strategic alternatives involving Horizon. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS. (c) EXHIBITS. 99.1 -- August 10, 2000 Press Release SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this current report to be signed on its behalf by the undersigned thereunto duly authorized. HORIZON PHARMACIES, INC. By: /s/ John N. Stogner -------------------------------------- John N. Stogner Chief Financial Officer Date: August 17, 2000 EXHIBIT INDEX
EXHIBIT NUMBER EXHIBIT TITLE ------ ------------- 99.1 -- August 10, 2000 Press Release